SCNX - Scienture Holdings, Inc.


0.417
-0.036   -8.513%

Share volume: 521,947
Last Updated: 03-27-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries: -0.09%

PREVIOUS CLOSE
CHG
CHG%

$0.45
-0.04
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
43%
Profitability 35%
Dept financing 23%
Liquidity 62%
Performance 50%
Company vs Stock growth
vs
Performance
5 Days
-13.97%
1 Month
-0.38%
3 Months
-18.46%
6 Months
-50.27%
1 Year
-73.10%
2 Year
-94.67%
Key data
Stock price
$0.42
P/E Ratio 
0.00
DAY RANGE
$0.40 - $0.46
EPS 
-$3.12
52 WEEK RANGE
$0.37 - $2.60
52 WEEK CHANGE
-$71.04
MARKET CAP 
13.703 M
YIELD 
N/A
SHARES OUTSTANDING 
40.631 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-10-2025
BETA 
2.80
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$467,820
AVERAGE 30 VOLUME 
$7,348,975
Company detail
CEO: Surendra Ajjarapu
Region: US
Website: scienture.com
Employees: 0
IPO year: 2009
Issue type:
Market: NASDAQ
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

SCIENTURE HOLDINGS, Inc is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the U.S.

Recent news